Search results
Fit for a dog? The latest science on CBD for pets
Popular Science via Yahoo News· 2 days agoThis article was originally featured on Knowable Magazine. 13-year-old Norwich terrier, previously limping and stiff, able to enjoy walks again. A toy...
11 Spearmint Tea Benefits You’ll Wish You Knew About Sooner
Prevention via Yahoo News· 4 days ago“It may!” declares Meshalum. “High testosterone is associated with unwanted facial hair in women, a...
Can This Well-Loved Herb Help Fight Malignancies?
Mercola· 3 days agoStudies2,3,4 also support the notion that this humble herb has anticancer effects, which should be good enough reason for you to include more of it in your diet. A study published in Biomedicine ...
The Science on CBD for Pets: Scientists Hope it Can Help 4-Legged Patients with Arthritis, Allergies...
GoodNewsNetwork· 22 hours agoA toy poodle with epilepsy, finally relieved from seizures. In case reports, these and other dogs...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize ...
11 Spearmint Tea Benefits You’ll Wish You Knew About Sooner
Prevention· 4 days agoSpearmint: it’s a popular flavor for mouthwash and chewing gum, but the invigorating herb can do a...
Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for...
WROC Rochester· 5 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a...
Visiting Vet: Captain Jack - The Martha's Vineyard Times
The Martha's Vineyard Times· 4 days agoCaptain Jack was a bad cat. In his prime, Jack was a huge fluff ball. Like most Island folks with...
Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment...
FOX21 Colorado Springs· 3 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize ...
